Chinese pharmaceuticals: Net profit will decrease by 48.91% in 2024 compared to the previous year.

China Pharmaceutical Announcement: In 2024, the operating income was 34.148 billion yuan, a year-on-year decrease of 12.04%. The net profit attributable to shareholders of the listed company was 535 million yuan, a year-on-year decrease of 48.91%. The company plans to distribute a cash dividend of 1.07 yuan per 10 shares to all shareholders for the year 2024. After deducting the interim cash dividend of 0.2174 yuan per 10 shares already distributed by the company, the company plans to distribute a cash dividend of 0.8565 yuan per 10 shares at the end of 2024. Based on the total share capital of 1.496 billion shares, the company plans to distribute a cash dividend of 128 million yuan at the end of 2024, in addition to the cash dividend of 32.5204 million yuan already distributed in the middle of 2024. The total amount of cash dividends distributed in 2024 will be 161 million yuan.